J. Udelson

Cardiology and Cardiovascular Medicine · 2002–2016

A researcher in the Science corpus: 18 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Cardiology and Cardiovascular Medicine — 205 citations into it

Whom J. Udelson trusts

Their strongest outbound trust, strongest first, inferred from their citations.

1. B. Maron (in Cardiology and Cardiovascular Medicine)

Papers from J. Udelson's perspective

Ordered by how strongly the researchers J. Udelson trusts endorse each paper. Same corpus, a different order for every researcher.

1. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. (JACC Cardiovascular Imaging)
2. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. (Journal of the American College of Cardiology)
3. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice… (Journal of Thoracic and Cardiovascular Surgery)
4. Assessment of Myocardial Fibrosis with Cardiac Magnetic Resonance (Journal of the American College of Cardiology)
5. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. (Journal of the American College of Cardiology)
6. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors
7. Acute Heart Failure Syndromes: Current State and Framework for Future Research (Circulation)
8. [Executive summary of the guidelines on the diagnosis and treatment of acute heart failure]. (Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology)
9. Controversies in ventricular remodelling. (The Lancet)
10. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. (New England Journal of Medicine)

Their papers

• Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2: Double-Blind, Randomized, Controlled Clinical Trial (2002) — 697 citations
• Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized Trials. (2016) — 625 citations
• Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy (2014) — 917 citations
• Coronary CT angiography versus standard evaluation in acute chest pain. (2012) — 861 citations
• Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. (2011) — 750 citations
• 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2011) — 1,435 citations
• 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Soci (2011) — 1,097 citations
• 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines (2011) — 937 citations
• 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2011) — 848 citations
• Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial. (2009) — 525 citations
• Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. (2008) — 648 citations
• Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. (2007) — 1,662 citations
• Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. (2007) — 858 citations
• Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction (2006) — 924 citations
• Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy (2006) — 637 citations
• Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. (2003) — 799 citations
• ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl (2003) — 1,490 citations
• Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. (2002) — 1,374 citations